Subscribe To
AURA / JMP Is Bullish On This Cancer Stock "Sees New Way to Treat Cancer"
AURA News
By The Motley Fool
February 10, 2023
Why Shares of Aura Biosciences Jumped This Week
The clinical-stage biotech may be ready to release updated phase 3 trial results on its lead therapy. more_horizontal
By Benzinga
July 19, 2022
JMP Is Bullish On This Cancer Stock "Sees New Way to Treat Cancer"
JMP Securities has initiated the coverage on Aura Biosciences Inc (NASDAQ: AURA) with a Market Outperform rating and a $26 risk-adjusted price ta more_horizontal